# cytarabine

NDC: 25021-229
Generic name: cytarabine
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20230601

FDA application: ANDA211937

## Active ingredients

- CYTARABINE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-229"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-229
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90f5c7ab-9f15-487d-ba69-ee4107434bcc